Oxidative stress, mitochondrial damage and diabetic retinopathy.

[1]  A. Kowluru,et al.  Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy , 2015, Progress in Retinal and Eye Research.

[2]  M. Mishra,et al.  Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy. , 2015, Investigative ophthalmology & visual science.

[3]  S. Richer,et al.  The Diabetes Visual Function Supplement Study (DiVFuSS) , 2015, British Journal of Ophthalmology.

[4]  R. Natarajan,et al.  Epigenetic mechanisms in diabetic complications and metabolic memory , 2015, Diabetologia.

[5]  Walter T Ambrosius,et al.  The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. , 2014, Ophthalmology.

[6]  F. Cipollone,et al.  Role of microRNAs in the modulation of diabetic retinopathy , 2014, Progress in Retinal and Eye Research.

[7]  M. Mishra,et al.  Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy. , 2014, Investigative ophthalmology & visual science.

[8]  M. Mishra,et al.  Retinal mitochondrial DNA mismatch repair in the development of diabetic retinopathy, and its continued progression after termination of hyperglycemia. , 2014, Investigative ophthalmology & visual science.

[9]  M. Mishra,et al.  Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. , 2014, Free radical biology & medicine.

[10]  L. Singh,et al.  Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy , 2014, Journal of ophthalmology.

[11]  R. Kowluru,et al.  Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. , 2014, Investigative ophthalmology & visual science.

[12]  M. Mishra,et al.  Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon. , 2014, Experimental eye research.

[13]  D. Candas,et al.  MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. , 2014, Antioxidants & redox signaling.

[14]  A. Kowluru,et al.  Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes. , 2014, Biochemical pharmacology.

[15]  A. Kowluru,et al.  TIAM1–RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy , 2014, Diabetologia.

[16]  R. Kowluru,et al.  Beneficial effects of the nutritional supplements on the development of diabetic retinopathy , 2014, Nutrition & Metabolism.

[17]  A. Simm,et al.  Role of advanced glycation end products in cellular signaling , 2014, Redox biology.

[18]  M. Mishra,et al.  Epigenetic Modifications and Diabetic Retinopathy , 2013, BioMed research international.

[19]  K. Palczewski,et al.  Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina , 2013, Proceedings of the National Academy of Sciences.

[20]  R. Kowluru,et al.  Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy. , 2013, Biochemical and biophysical research communications.

[21]  G. Andria,et al.  Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. , 2013, Molecular genetics and metabolism.

[22]  R. Caldwell,et al.  Arginase in retinopathy , 2013, Progress in Retinal and Eye Research.

[23]  Xiongwei Zhu,et al.  Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. , 2013, Antioxidants & redox signaling.

[24]  R. Kowluru,et al.  Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy , 2013, Diabetes.

[25]  M. Mishra,et al.  Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. , 2013, Investigative ophthalmology & visual science.

[26]  S. Whelan,et al.  Mitochondrial Signaling: Forwards, Backwards, and In Between , 2013, Oxidative medicine and cellular longevity.

[27]  D. E. Hamassaki,et al.  Green tea is neuroprotective in diabetic retinopathy. , 2013, Investigative ophthalmology & visual science.

[28]  J. Gross,et al.  The UCP1 -3826A/G polymorphism is associated with diabetic retinopathy and increased UCP1 and MnSOD2 gene expression in human retina. , 2012, Investigative ophthalmology & visual science.

[29]  R. Kowluru,et al.  A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathy. , 2012, Free radical biology & medicine.

[30]  N. Congdon,et al.  The worldwide epidemic of diabetic retinopathy , 2012, Indian journal of ophthalmology.

[31]  R. Scarpulla.  Nucleus-encoded regulators of mitochondrial function: integration of respiratory chain expression, nutrient sensing and metabolic stress. , 2012, Biochimica et biophysica acta.

[32]  Shikha Tewari,et al.  Damaged mitochondrial DNA replication system and the development of diabetic retinopathy. , 2012, Antioxidants & redox signaling.

[33]  R. Kowluru,et al.  Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. , 2012, Investigative ophthalmology & visual science.

[34]  M. Miyagi,et al.  Acetylation of Retinal Histones in Diabetes Increases Inflammatory Proteins , 2012, The Journal of Biological Chemistry.

[35]  M. Porta,et al.  Human pericyte–endothelial cell interactions in co-culture models mimicking the diabetic retinal microvascular environment , 2012, Acta Diabetologica.

[36]  M. Nebbioso,et al.  Oxidative stress in preretinopathic diabetes subjects and antioxidants. , 2012, Diabetes technology & therapeutics.

[37]  R. Ramasamy,et al.  Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications , 2011, Annals of the New York Academy of Sciences.

[38]  R. Eglen,et al.  Screening for Compounds That Modulate Epigenetic Regulation of the Transcriptome , 2011, Journal of biomolecular screening.

[39]  R. Kowluru,et al.  Diabetic retinopathy and damage to mitochondrial structure and transport machinery. , 2011, Investigative ophthalmology & visual science.

[40]  Renu A. Kowluru,et al.  Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage , 2011, Diabetes.

[41]  J. Martín-Subero.  How epigenomics brings phenotype into being. , 2011, Pediatric endocrinology reviews : PER.

[42]  H. Parving,et al.  Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes , 2011, Diabetes.

[43]  A. Harel-Bellan,et al.  Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats , 2011, Molecular vision.

[44]  I. Shimomura,et al.  Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes. , 2011, Diabetes research and clinical practice.

[45]  A. Goldberg,et al.  Mitochondrial biogenesis and the development of diabetic retinopathy. , 2011, Free radical biology & medicine.

[46]  R. Kowluru,et al.  Epigenetic Changes in Mitochondrial Superoxide Dismutase in the Retina and the Development of Diabetic Retinopathy , 2011, Diabetes.

[47]  Alan W. Stitt.  AGEs and diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.

[48]  A. Daiber.  Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. , 2010, Biochimica et biophysica acta.

[49]  Y. Ho,et al.  Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase , 2010, Free radical research.

[50]  L. Aiello,et al.  Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy , 2009, Nature Medicine.

[51]  Lydia W. S. Finley,et al.  The coordination of nuclear and mitochondrial communication during aging and calorie restriction , 2009, Ageing Research Reviews.

[52]  M. Goligorsky,et al.  Mitochondria and reactive oxygen species. , 2009, Hypertension.

[53]  R. Frey,et al.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. , 2009, Antioxidants & redox signaling.

[54]  R. Dahiya,et al.  BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. , 2009, Carcinogenesis.

[55]  Kyung-Chul Choi,et al.  Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. , 2009, Cancer research.

[56]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[57]  J. Zhang,et al.  Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. , 2008, Archives of ophthalmology.

[58]  B. Menon,et al.  Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. , 2008, Investigative ophthalmology & visual science.

[59]  T. Kern,et al.  Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy , 2007, Experimental diabetes research.

[60]  T. Kern,et al.  Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. , 2007, Investigative ophthalmology & visual science.

[61]  Renu A. Kowluru,et al.  Oxidative Stress and Diabetic Retinopathy , 2007, Experimental diabetes research.

[62]  Dawn G. Smith,et al.  Glyoxalase I Is Critical for Human Retinal Capillary Pericyte Survival under Hyperglycemic Conditions* , 2006, Journal of Biological Chemistry.

[63]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[64]  R. Cutler.  Oxidative Stress Profiling: , 2005, Annals of the New York Academy of Sciences.

[65]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[66]  R. Kowluru,et al.  Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. , 2004, Diabetes.

[67]  R. Kowluru,et al.  Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. , 2004, Investigative ophthalmology & visual science.

[68]  C. Szabó,et al.  Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-κB , 2004 .

[69]  R. Klein,et al.  Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. , 2004, The American journal of clinical nutrition.

[70]  J. Locicero,et al.  Overexpressed nuclear factor kappaB correlates with enhanced expression of interleukin-1beta and inducible nitric oxide synthase in aged murine lungs to endotoxic stress. , 2004, The Annals of thoracic surgery.

[71]  J. Russell,et al.  Nitrosative Injury and Antioxidant Therapy in the Management of Diabetic Neuropathy , 2004, Journal of Investigative Medicine.

[72]  T. Hikichi,et al.  Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats , 2004, Current eye research.

[73]  R. Kowluru,et al.  Diabetes-induced mitochondrial dysfunction in the retina. , 2003, Investigative ophthalmology & visual science.

[74]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[75]  A. J. Lambert,et al.  A signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling , 2003, The EMBO journal.

[76]  Alan W. Stitt,et al.  The role of advanced glycation in the pathogenesis of diabetic retinopathy. , 2003, Experimental and molecular pathology.

[77]  R. Kowluru.  Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. , 2003, Diabetes.

[78]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[79]  C. Roussos,et al.  Antioxidants attenuate the plasma cytokine response to exercise in humans. , 2003, Journal of applied physiology.

[80]  S. Chakrabarti,et al.  Diabetes-induced Activation of Nuclear Transcriptional Factor in the Retina, and its Inhibition by Antioxidants , 2003, Free radical research.

[81]  Timothy S Kern,et al.  Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.

[82]  R. Kowluru.  Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated , 2001, Acta Diabetologica.

[83]  T. Gardner,et al.  Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons* , 2001, The Journal of Biological Chemistry.

[84]  J. Provis.  Development of the Primate Retinal Vasculature , 2001, Progress in Retinal and Eye Research.

[85]  J. Dunlap,et al.  Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve , 2001, British journal of pharmacology.

[86]  J. Tang,et al.  Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. , 2001, Diabetes.

[87]  E. Balestrazzi,et al.  Treatment of vascular retinopathies with Pycnogenol® , 2001, Phytotherapy research : PTR.

[88]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R Gopalakrishna,et al.  Protein kinase C signaling and oxidative stress. , 2000, Free radical biology & medicine.

[90]  L. Aiello,et al.  High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. , 1999, Diabetes care.

[91]  B. Reboussin,et al.  Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. , 1998, Ophthalmology.

[92]  A. Mansour,et al.  Prevention of pericyte loss by trolox in diabetic rat retina. , 1998, Journal of toxicology and environmental health. Part A.

[93]  H. Hammes,et al.  Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.

[94]  T. Kern,et al.  Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.

[95]  M. Lorenzi,et al.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.

[96]  B. Trumpower,et al.  The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. , 1990, The Journal of biological chemistry.

[97]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.

[98]  Yuko Sato,et al.  (-)-epigallocatechin-3-gallate , 2014 .

[99]  I. Young,et al.  The Pro-Oxidant Activity of High-Dose Vitamin E Supplements in Vivo , 2012, BioDrugs.

[100]  Ronald Klein,et al.  The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy. , 2010, Ophthalmology.

[101]  J. Vijg,et al.  Epigenetic factors in aging and longevity , 2009, Pflügers Archiv - European Journal of Physiology.

[102]  L. Aiello,et al.  Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema. , 2009, Investigative ophthalmology & visual science.

[103]  Nutrition & Metabolism BioMed Central , 2007 .

[104]  P. Hannaert,et al.  Calcium Dobesilate in the Treatment of Diabetic Retinopathy , 2005, Treatments in endocrinology.

[105]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. , 2004, Diabetes.

[106]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[107]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. , 1997, Free radical biology & medicine.

[108]  D. Armstrong,et al.  Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. , 1991, Free radical biology & medicine.

[109]  R. E. Anderson,et al.  Lipid peroxidation and retinal degeneration. , 1984, Current eye research.